Evidence map›Paper›PMID 26864323›Full record

ArticleScientific reports2016

Inflammation increases NOTCH1 activity via MMP9 and is counteracted by Eicosapentaenoic Acid-free fatty acid in colon cancer cells.

Chiara Fazio, Giulia Piazzi, Paola Vitaglione, Vincenzo Fogliano, Alessandra Munarini, Anna Prossomariti, Maddalena Milazzo, Leonarda D'Angelo, Manuela Napolitano, Pasquale Chieco and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Notch signaling in cancers: mechanism and potential therapy.Frontiers in cell and developmental biology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Comparison of anti-inflammatory effects ofChinese herbal medicines · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Chiara FazioDepartment of Surgical and Medical Sciences, University of Bologna, Bologna, Italy.
Giulia PiazziDepartment of Surgical and Medical Sciences, University of Bologna, Bologna, Italy.
Paola VitaglioneDepartment of Food Science, University of Naples "Federico II", Portici (NA), Italy.
Vincenzo FoglianoFood Quality & Design group, Wageningen University, Wageningen, The Netherlands.
Alessandra MunariniDepartment of Surgical and Medical Sciences, University of Bologna, Bologna, Italy.
Anna ProssomaritiDepartment of Surgical and Medical Sciences, University of Bologna, Bologna, Italy.
Maddalena MilazzoCenter for Applied Biomedical Research (CRBA), S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Leonarda D'AngeloDepartment of Surgical and Medical Sciences, University of Bologna, Bologna, Italy.
Manuela NapolitanoDepartment of Surgical and Medical Sciences, University of Bologna, Bologna, Italy.
Pasquale ChiecoCenter for Applied Biomedical Research (CRBA), S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Andrea BelluzziGastroenterology Unit S.Orsola-Malpighi Hospital, Bologna, Italy.
Franco BazzoliDepartment of Surgical and Medical Sciences, University of Bologna, Bologna, Italy.
Luigi RicciardielloDepartment of Surgical and Medical Sciences, University of Bologna, Bologna, Italy.
University of Bologna · ITPoliclinico S.Orsola-Malpighi · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aberrant NOTCH1 signalling is critically involved in multiple models of colorectal cancer (CRC) and a prominent role of NOTCH1 activity during inflammation has emerged. Epithelial to Mesenchymal Transition (EMT), a crucial event promoting malignant transformation, is regulated by inflammation and Metalloproteinase-9 (MMP9) plays an important role in this process. Eicosapentaenoic Acid (EPA), an omega-3 polyunsaturated fatty acid, was shown to prevent colonic tumors in different settings. We recently found that an extra-pure formulation of EPA as Free Fatty Acid (EPA-FFA) protects from colon cancer development in a mouse model of Colitis-Associated Cancer (CAC) through modulation of NOTCH1 signalling. In this study, we exposed colon cancer cells to an inflammatory stimulus represented by a cytokine-enriched Conditioned Medium (CM), obtained from THP1-differentiated macrophages. We found, for the first time, that CM strongly up-regulated NOTCH1 signalling and EMT markers, leading to increased invasiveness. Importantly, NOTCH1 signalling was dependent on MMP9 activity, upon CM exposure. We show that a non-cytotoxic pre-treatment with EPA-FFA antagonizes the effect of inflammation on NOTCH1 signalling, with reduction of MMP9 activity and invasiveness. In conclusion, our data suggest that, in CRC cells, inflammation induces NOTCH1 activity through MMP9 up-regulation and that this mechanism can be counteracted by EPA-FFA.

Indexed as

Cell DifferentiationCell LineCell MovementCulture Media, ConditionedCytokinesEicosapentaenoic AcidEpithelial-Mesenchymal TransitionGene Expression RegulationHCT116 CellsHT29 CellsHumansInflammationLipopolysaccharidesMatrix Metalloproteinase 9MonocytesReceptor, Notch1Culture Media, ConditionedCytokinesEicosapentaenoic AcidLipopolysaccharidesMatrix Metalloproteinase 9MMP9 protein, humanNOTCH1 protein, humanReceptor, Notch1Tetradecanoylphorbol Acetate

Identifiers

PMID26864323
PMCPMC4749954
OpenAlexW2272988130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.